Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $148.8600 (-1.43%) ($148.8600 - $148.8600) on Thu. Apr. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.1% (three month average) | RSI | 42 | Latest Price | $148.8600(-1.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.55% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) IGOV(-5%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.55% (StdDev 5.1%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $145.36(-2.35%) | Resistance Level | $152.51 | 5 Day Moving Average | $149.01(-0.1%) | 10 Day Moving Average | $151.42(-1.69%) | 20 Day Moving Average | $152.51(-2.39%) | To recent high | -31% | To recent low | 20.8% | Market Cap | $2.392b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |